CPC Biotech has introduced the RevolveSD™ Series — a new single-use sterile disconnect device designed for one-inch bioprocessing tubing. This innovation will allow operators to achieve a sterile separation in a matter of seconds without requiring specialized equipment like clamps or thermal sealers.
CPC Biotech's RevolveSD™ Series is constructed from durable and lightweight polyphenylsulfone. The product is engineered to withstand aggressive chemicals commonly found in advanced manufacturing applications such as antibody-drug conjugates, and its metal-free composition eliminates the risk of corrosion within the fluid path. The connector incorporates dual-valve, non-spill technology that minimizes fluid residue upon disconnection, while its one-inch bore and valve architecture are designed to support smooth, bidirectional flow with reduced turbulence and restriction. As a true single-use disconnect, RevolveSD™ Series inherently prevents the possibility of unintended reconnection, thereby mitigating a key risk of sterility breaches that can compromise an entire production batch.
Single-Use Sterile Bioprocessing Tools
CPC Biotech Calls Attention to the RevolveSD™ Series
Trend Themes
-
Single-use Bioprocessing — Disposable sterile connectors are reshaping biomanufacturing workflows by reducing cleaning validation, contamination risk, and downtime in high-value production environments.
-
Tool-free Sterile Separation — Fast disconnect systems that eliminate clamps and thermal sealers create efficiency gains for operators managing complex sterile fluid transfers.
-
Metal-free Fluid Paths — Corrosion-resistant polymer components support safer processing of aggressive chemistries, especially in advanced therapies and antibody-drug conjugate manufacturing.
Industry Implications
-
Biopharmaceutical Manufacturing — Sterile single-use technologies are expanding production flexibility while helping protect costly biologic batches from contamination-related losses.
-
Medical Device Components — Precision-engineered sterile connectors present opportunities for component suppliers serving regulated fluid management and aseptic processing applications.
-
Advanced Therapy Production — Cell, gene, and conjugate therapy facilities benefit from closed-system innovations that improve sterility assurance in sensitive manufacturing workflows.